Could hearing problems be an early sign of brain disease?

NCT ID NCT07083089

Recruiting now Knowledge-focused Sponsor: Cilcare SAS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at hearing in people with early-stage Alzheimer's or Parkinson's disease, compared to healthy volunteers. Researchers will use detailed hearing tests to find out how common different types of hearing loss are, especially 'hidden hearing loss' where standard tests are normal but understanding speech in noisy places is hard. The goal is to learn more about the link between hearing and brain health, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify early hearing-related signs of neurodegenerative diseases, leading to better screening tools.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to direct benefits for participants, and findings may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS MILD COGNITIVE IMPAIRMENT (MCI) AMNESTIC PARKINSON DISEASE (PD)

Contacts and locations

Locations

CHU Carémeau
RECRUITING

Nîmes, 30900, France
CHU Gui de Chauliac
RECRUITING

Montpellier, 34080, France
CHU Nice
RECRUITING

Nice, 06000, France
Hospices Civils de Lyon, Hôpital des Charpennes
RECRUITING

Villeurbanne, 69100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.